VentriPoint Diagnostics (VPT) Hits New 12-Month Low at $0.11

Share on StockTwits

VentriPoint Diagnostics Ltd. (CVE:VPT)’s share price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as C$0.11 and last traded at C$0.11, with a volume of 16000 shares. The stock had previously closed at C$0.11.

The stock has a market capitalization of $7.76 million and a PE ratio of -2.08.

COPYRIGHT VIOLATION NOTICE: “VentriPoint Diagnostics (VPT) Hits New 12-Month Low at $0.11” was originally reported by Week Herald and is owned by of Week Herald. If you are viewing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The correct version of this piece of content can be viewed at

About VentriPoint Diagnostics (CVE:VPT)

Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease primarily in Canada, the Unites States, and China. The company offers Ventripoint Medical System, medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers.

Featured Story: How is the discount rate different from the Federal Funds rate?

Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with's FREE daily email newsletter.